Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Evogene

EVGN
Current price
0.73 USD +0.05 USD (+7.35%)
Last closed 0.69 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 34 929 912 USD
Yield for 12 month +16.78 %
Week
Month
Year
EVGN
21.11.2021 - 28.11.2021

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. Address: 13 Gad Feinstein Street, Rehovot, Israel, 7414002

Analytics

WallStreet Target Price

3.62 USD

P/E ratio

Dividend Yield

Current Year

+1 675 000 USD

Last Year

+930 000 USD

Current Quarter

+3 767 000 USD

Last Quarter

+654 000 USD

Current Year

+766 000 USD

Last Year

+163 000 USD

Current Quarter

+3 256 000 USD

Last Quarter

+193 000 USD

Key Figures EVGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -20 798 000 USD
Operating Margin TTM -111.04 %
PE Ratio
Return On Assets TTM -24.18 %
PEG Ratio
Return On Equity TTM -60.51 %
Wall Street Target Price 3.62 USD
Revenue TTM 5 722 000 USD
Book Value 0.37 USD
Revenue Per Share TTM 0.13 USD
Dividend Share
Quarterly Revenue Growth YOY 708.4 %
Dividend Yield
Gross Profit TTM 766 000 USD
Earnings Share -0.47 USD
Diluted Eps TTM -0.47 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics EVGN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EVGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:2
Payout Ratio
Last Split Date 19.11.2013
Dividend Date

Stock Valuation EVGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.2953
Price Sales TTM 6.1045
Enterprise Value EBITDA -0.3328
Price Book MRQ 1.9362

Financials EVGN

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators EVGN

For 52 weeks

0.45 USD 1.44 USD
50 Day MA 0.57 USD
Shares Short Prior Month 180 362
200 Day MA 0.72 USD
Short Ratio 2.18
Shares Short 217 497
Short Percent 0.44 %